Cargando…
Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes
OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434519/ https://www.ncbi.nlm.nih.gov/pubmed/32884330 http://dx.doi.org/10.2147/IJGM.S258953 |
_version_ | 1783572164531716096 |
---|---|
author | Abbasi-Ghahramanloo, Abbas Soltani-Kermanshahi, Mojtaba Mansori, Kamyar Khazaei-Pool, Maryam Sohrabi, Masoudreza Baradaran, Hamid Reza Talebloo, Zahra Gholami, Ali |
author_facet | Abbasi-Ghahramanloo, Abbas Soltani-Kermanshahi, Mojtaba Mansori, Kamyar Khazaei-Pool, Maryam Sohrabi, Masoudreza Baradaran, Hamid Reza Talebloo, Zahra Gholami, Ali |
author_sort | Abbasi-Ghahramanloo, Abbas |
collection | PubMed |
description | OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated to Neyshabur County (Iran) in 2012. In addition to demographic information, two questionnaires WHOQoL-BREF and SF-36 questionnaires were used for data collection. Cronbach’s alpha coefficient was used for scale reliability. We conducted an exploratory factor analysis for the investigation of construct validity. Convergent and discriminant validity were analyzed using Spearman correlation coefficient. To determine the relationships between the eight domains of SF-36 and four domains of the WHOQoL-BREF, structural equation modelling was performed. RESULTS: Cronbach’s alpha coefficients were acceptable for all domains of both WHOQoL-BREF (0.69–0.86) and SF-36 (0.63 −0.92) questionnaires. The principal component analysis showed two separate factors: one for all domains of SF-36 and another for all domains of WHOQoL-BREF. Spearman correlation coefficients of both instruments were partly to strongly correlated with most domains (r ≥0.40). Correlations for domains with similar constructs were stronger than those measuring varied constructs. Structural equation modelling recommended approximately moderate relationships among the SF-36 and WHOQoL-BREF domains. CONCLUSION: Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments for clinical and research uses, respectably. However, results of the goodness of fit showed that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered more suitable for the study population. |
format | Online Article Text |
id | pubmed-7434519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-74345192020-09-02 Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes Abbasi-Ghahramanloo, Abbas Soltani-Kermanshahi, Mojtaba Mansori, Kamyar Khazaei-Pool, Maryam Sohrabi, Masoudreza Baradaran, Hamid Reza Talebloo, Zahra Gholami, Ali Int J Gen Med Original Research OBJECTIVE: This study aimed to compare the quality of life (QoL) in patients with type 2 diabetes using two WHOQoL -BREF and SF-36 questionnaires in Iran. PATIENTS AND METHODS: In this cross-sectional study, 1847 patients with type 2 diabetes were recruited from rural health-care centers affiliated to Neyshabur County (Iran) in 2012. In addition to demographic information, two questionnaires WHOQoL-BREF and SF-36 questionnaires were used for data collection. Cronbach’s alpha coefficient was used for scale reliability. We conducted an exploratory factor analysis for the investigation of construct validity. Convergent and discriminant validity were analyzed using Spearman correlation coefficient. To determine the relationships between the eight domains of SF-36 and four domains of the WHOQoL-BREF, structural equation modelling was performed. RESULTS: Cronbach’s alpha coefficients were acceptable for all domains of both WHOQoL-BREF (0.69–0.86) and SF-36 (0.63 −0.92) questionnaires. The principal component analysis showed two separate factors: one for all domains of SF-36 and another for all domains of WHOQoL-BREF. Spearman correlation coefficients of both instruments were partly to strongly correlated with most domains (r ≥0.40). Correlations for domains with similar constructs were stronger than those measuring varied constructs. Structural equation modelling recommended approximately moderate relationships among the SF-36 and WHOQoL-BREF domains. CONCLUSION: Our study suggests that SF-36 and WHOQoL-BREF are reliable instruments for clinical and research uses, respectably. However, results of the goodness of fit showed that the WHOQoL-BREF was fitted well. Also, the WHOQoL-BREF can be considered more suitable for the study population. Dove 2020-08-11 /pmc/articles/PMC7434519/ /pubmed/32884330 http://dx.doi.org/10.2147/IJGM.S258953 Text en © 2020 Abbasi-Ghahramanloo et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Abbasi-Ghahramanloo, Abbas Soltani-Kermanshahi, Mojtaba Mansori, Kamyar Khazaei-Pool, Maryam Sohrabi, Masoudreza Baradaran, Hamid Reza Talebloo, Zahra Gholami, Ali Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title | Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title_full | Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title_fullStr | Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title_full_unstemmed | Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title_short | Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes |
title_sort | comparison of sf-36 and whoqol-bref in measuring quality of life in patients with type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434519/ https://www.ncbi.nlm.nih.gov/pubmed/32884330 http://dx.doi.org/10.2147/IJGM.S258953 |
work_keys_str_mv | AT abbasighahramanlooabbas comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT soltanikermanshahimojtaba comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT mansorikamyar comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT khazaeipoolmaryam comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT sohrabimasoudreza comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT baradaranhamidreza comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT talebloozahra comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes AT gholamiali comparisonofsf36andwhoqolbrefinmeasuringqualityoflifeinpatientswithtype2diabetes |